Cargando…

Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency

INTRODUCTION: The expanded capacity of syringe services programs (SSPs) in the USA to integrate telehealth services was largely related to flexibility of buprenorphine prescription in response to the COVID-19 pandemic. SSPs demonstrated the potential of using telehealth to reach participants with bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartholomew, Tyler S., Tookes, Hansel E., Chueng, Teresa A., Bluthenthal, Ricky N., Wenger, Lynn D., Kral, Alex H., Lambdin, Barrot H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475193/ https://www.ncbi.nlm.nih.gov/pubmed/37660029 http://dx.doi.org/10.1186/s12954-023-00861-3

Ejemplares similares

How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study
por: Lambdin, Barrot H., et al.
Publicado: (2023)

Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises
por: Wenger, Lynn D., et al.
Publicado: (2021)

Overdose Education and Naloxone Distribution Within Syringe Service Programs — United States, 2019
por: Lambdin, Barrot H., et al.
Publicado: (2020)

Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
por: Lambdin, Barrot H., et al.
Publicado: (2022)

Syringe services program (SSP) operational changes during the COVID-19 global outbreak
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs
por: Patel, Sheila V., et al.
Publicado: (2023)

Application of machine learning algorithms for localized syringe services program policy implementation – Florida, 2017
por: Bartholomew, Tyler S., et al.
Publicado: (2022)

The University of Miami Infectious Disease Elimination Act Syringe Services Program: A Blueprint for Student Advocacy, Education, and Innovation
por: Tookes, Hansel, et al.
Publicado: (2020)

Implementation and first-year operating costs of an academic medical center-based syringe services program
por: Bartholomew, Tyler S., et al.
Publicado: (2021)

Systems analysis and improvement approach to improve naloxone distribution within syringe service programs: study protocol of a randomized controlled trial
por: Akiba, Christopher F., et al.
Publicado: (2023)

Best practices for community-based overdose education and naloxone distribution programs: results from using the Delphi approach
por: Wenger, Lynn D., et al.
Publicado: (2022)

2667. Bridging the Gap: Sexually Transmitted Infections Testing, Treatment, and Prevention at a Miami Syringe Services Program for Women Who Inject Drugs
por: Herrera, Tara E, et al.
Publicado: (2023)

“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs
por: Bartholomew, Tyler S., et al.
Publicado: (2022)

Baseline differences in characteristics and risk behaviors among people who inject drugs by syringe exchange program modality: an analysis of the Miami IDEA syringe exchange
por: Iyengar, Siddharth, et al.
Publicado: (2019)

Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida
por: Jo, Young, et al.
Publicado: (2020)

When is an abscess more than an abscess? Syringe services programs and the harm reduction safety-net: a case report
por: Castillo, Marcus, et al.
Publicado: (2020)

Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

Correction to: When is an abscess more than an abscess? Syringe services programs and the harm reduction safety-net: a case report
por: Castillo, Marcus, et al.
Publicado: (2020)

Correlates of injection‐related wounds and skin infections amongst persons who inject drugs and use a syringe service programme: A single center study
por: Cahn, Brian A., et al.
Publicado: (2021)

Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

1643. Infectious Sequelae of Injection Drug Use at a County Safety-Net Hospital Decline Following Establishment of a Syringe Service Program
por: Bornstein, Kasha J, et al.
Publicado: (2019)

Hospital admissions among people who inject opioids following syringe services program implementation
por: Bornstein, K. J., et al.
Publicado: (2020)

Wounds and Skin and Soft Tissue Infections in People Who Inject Drugs and the Utility of Syringe Service Programs in Their Management
por: Sanchez, Daniela P., et al.
Publicado: (2021)

Access to Sterile Syringes through San Francisco Pharmacies and the Association with HIV Risk Behavior among Injection Drug Users
por: Riley, Elise D., et al.
Publicado: (2010)

Reduced Emergency Department Visits and Hospitalisation with Use of an Unsanctioned Safe Consumption Site for Injection Drug Use in the United States
por: Lambdin, Barrot H., et al.
Publicado: (2022)

Measures of harm reduction service provision for people who inject drugs
por: O’Keefe, Daniel, et al.
Publicado: (2019)

Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey
por: Syros, Alina, et al.
Publicado: (2022)

Health risk associated with residential relocation among people who inject drugs in Los Angeles and San Francisco, CA: a cross sectional study
por: Chiang, Joey C., et al.
Publicado: (2022)

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study
por: Suarez, Edward, et al.
Publicado: (2023)

Service integration: opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania
por: Lambdin, Barrot H, et al.
Publicado: (2015)

Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016–2017
por: Serota, David P, et al.
Publicado: (2020)

Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California
por: Lambdin, Barrot H., et al.
Publicado: (2017)

Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
por: Jakubowski, Andrea, et al.
Publicado: (2022)

THE PLANNING AND ORGANIZATION OF CENTRAL SYRINGE SERVICES
Publicado: (1958)

Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021
por: Des Jarlais, Don C., et al.
Publicado: (2022)

Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania
por: Cooke, Alexis, et al.
Publicado: (2017)

Pharmacy Participation in Non-Prescription Syringe Sales in Los Angeles and San Francisco Counties, 2007
por: Cooper, Erin N., et al.
Publicado: (2010)

Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study
por: Hervera, Belén, et al.
Publicado: (2023)

A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City
por: Beharie, Nisha, et al.
Publicado: (2023)

Three Years after Legalization of Nonprescription Pharmacy Syringe Sales in California: Where Are We Now?
por: Garfein, Richard S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_he9ikqejrrqrn5o1mngk413drv